What are the cefdinir dosing recommendations for acute otitis media in children ≥6 months and adults, including renal‑function adjustments and treatment duration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefdinir Dosing for Acute Otitis Media

For acute otitis media, cefdinir should be dosed at 14 mg/kg/day (maximum 600 mg/day) administered either once daily or divided into two doses for 10 days in children ≥6 months, and 300 mg twice daily in adults. 1

Pediatric Dosing (≥6 Months Through 12 Years)

  • Standard dose: 7 mg/kg every 12 hours OR 14 mg/kg once daily for 5-10 days 1
  • Maximum daily dose: 600 mg/day regardless of weight 1
  • Once-daily dosing for 10 days demonstrates equivalent efficacy to twice-daily dosing 1
  • Cefdinir may be administered without regard to meals 1

Weight-Based Dosing Chart (Using 250 mg/5 mL Suspension)

  • 18 kg (40 lbs): 2.5 mL every 12 hours OR 5 mL once daily 1
  • 27 kg (60 lbs): 3.75 mL every 12 hours OR 7.5 mL once daily 1
  • 36 kg (80 lbs): 5 mL every 12 hours OR 10 mL once daily 1
  • ≥43 kg (95 lbs): 6 mL every 12 hours OR 12 mL once daily (maximum dose) 1

Adult Dosing

  • Standard dose: 300 mg twice daily for 10 days 1
  • Alternative: 600 mg once daily may be considered based on pharmacokinetic profile 2

When Cefdinir Is Appropriate

Cefdinir serves as a second-line agent, not first-line therapy for acute otitis media. 3

  • Non-Type I penicillin allergy: Cefdinir is the preferred cephalosporin for patients with non-serious hypersensitivity reactions to penicillin (such as rash), as cross-reactivity risk is negligible at approximately 0.1% 3
  • Treatment failure: Consider cefdinir when patients fail to respond to initial amoxicillin therapy within 48-72 hours 3
  • DO NOT use for Type I hypersensitivity: Patients with anaphylaxis or angioedema to penicillins should receive macrolides or clindamycin instead 4

Renal Dose Adjustments

Pediatric Patients with Renal Insufficiency

  • Creatinine clearance <30 mL/min/1.73 m²: 7 mg/kg (maximum 300 mg) once daily 1
  • Hemodialysis: 7 mg/kg (maximum 300 mg) every other day, with an additional dose after each dialysis session 1

Adult Patients with Renal Insufficiency

  • Creatinine clearance <30 mL/min: 300 mg once daily 1
  • Hemodialysis: 300 mg every other day, with 300 mg administered after each dialysis session 1

Treatment Duration Considerations

  • Standard duration: 10 days is recommended by the American Academy of Otolaryngology-Head and Neck Surgery 4
  • 5-day regimen: While FDA-approved for 5-10 days 1, a head-to-head trial demonstrated that 5 days of cefdinir (14 mg/kg/day) resulted in significantly lower cure rates (71%) compared to 10 days of high-dose amoxicillin-clavulanate (86.5%, p=0.001) 5
  • The cure rate with cefdinir decreased as children aged from 6-24 months, suggesting weight-based dosing may be inadequate in older/heavier children 5

Clinical Efficacy and Limitations

  • Comparative effectiveness: Cefdinir at 14 mg/kg/day for 5 days was inferior to amoxicillin-clavulanate 80 mg/kg/day for 10 days in validated otoscopy studies 6, 5
  • Pathogen coverage: Cefdinir demonstrates 97-99% susceptibility against H. influenzae including beta-lactamase producers, but lacks clinically significant activity against drug-resistant S. pneumoniae (DRSP) 3
  • Recurrent AOM: Cefdinir showed 72% eradication rates for recurrent AOM caused by H. influenzae 3
  • Higher doses ineffective: Even at 25 mg/kg/day, cefdinir fails to achieve adequate pharmacodynamic targets (<40% time above MIC) for penicillin-nonsusceptible S. pneumoniae, making it ineffective against resistant strains 7

Reassessment Algorithm After Treatment Failure

If no improvement occurs after 48-72 hours of cefdinir therapy: 3

  1. Confirm diagnosis: Reassess to verify AOM and exclude alternative diagnoses 3
  2. Switch antibiotics: Change to high-dose amoxicillin-clavulanate (90 mg/kg/day of amoxicillin with 6.4 mg/kg/day of clavulanate in 2 divided doses) 3
  3. Consider parenteral therapy: Ceftriaxone 50 mg/kg IM or IV for 3 days is an alternative 3

Key Clinical Pitfalls

  • Misclassifying penicillin allergy: Distinguish Type I reactions (anaphylaxis, angioedema) from non-serious reactions (rash)—cefdinir is safe only for the latter 3, 4
  • Using as first-line therapy: High-dose amoxicillin (80-90 mg/kg/day) remains the gold standard initial treatment due to superior effectiveness, safety, cost, and narrow spectrum 3
  • Inadequate duration: The 5-day regimen shows inferior outcomes; use 10-day courses for optimal efficacy 5
  • Geographic resistance patterns: In areas with high DRSP prevalence, cefdinir provides insufficient coverage and should be avoided 3
  • Palatability advantage: The oral suspension has superior taste compared to other antimicrobials, which may improve adherence in children 3, 8

Suspension Preparation

  • Stability: After reconstitution, suspension remains stable for 10 days at room temperature (25°C/77°F) 1
  • Storage: Keep container tightly closed and shake well before each administration 1
  • Discard: Any unused portion must be discarded after 10 days 1

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.